Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mirabegron”

154 trials

Showing 20 of 154 results

Not applicableStudy completedNCT07018934
What this trial is testing

Alfuzosin and Mirabegron for Double-J Stent Symptoms

Who this might be right for
Ureteral Stent-Related Symptoms
University of Gaziantep 100
Testing effectiveness (Phase 2)Study completedNCT02599480
What this trial is testing

Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure

Who this might be right for
Hypertrophy, Left Ventricular
Jean-Luc Balligand 296
Large-scale testing (Phase 3)Active Not RecruitingNCT07398261
What this trial is testing

Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children

Who this might be right for
Treatment of Non-monosymptomatic Nocturnal Enuresis
Menoufia University 151
Early research (Phase 1)Study completedNCT01476800
What this trial is testing

Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Adult Volunteers

Who this might be right for
Healthy SubjectsPharmacokinetics of YM178
Astellas Pharma Inc 24
Post-approval studies (Phase 4)Looking for participantsNCT05051436
What this trial is testing

The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics

Who this might be right for
Pre-diabetesObesity
Philip Kern 96
Post-approval studies (Phase 4)Study completedNCT02086188
What this trial is testing

Study of Behavioral Modification Program and Mirabegron to Improve Urinary Urgency in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Theodore R. Brown, MD MPH 28
Post-approval studies (Phase 4)Study completedNCT02294396
What this trial is testing

Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.

Who this might be right for
Overactive Bladder (OAB)
Astellas Pharma Inc 649
Large-scale testing (Phase 3)Study completedNCT00662909
What this trial is testing

Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Inc 2,149
Post-approval studies (Phase 4)Study completedNCT03558919
What this trial is testing

Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder

Who this might be right for
Overactive Bladder
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 81
Early research (Phase 1)Study completedNCT00856570
What this trial is testing

A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects

Who this might be right for
Overactive BladderPharmacokinetics
Astellas Pharma Inc 24
Early research (Phase 1)Study completedNCT01199523
What this trial is testing

Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and Females

Who this might be right for
Healthy Subjects
Astellas Pharma Inc 352
Not applicableStudy completedNCT01898624
What this trial is testing

Specified Drug Use-results Survey of Betanis Tablets

Who this might be right for
Overactive Bladder
Astellas Pharma Inc 300
Not applicableStudy completedNCT01901120
What this trial is testing

Long-Term Specified Drug Use-results Survey of Betanis Tablets

Who this might be right for
Overactive Bladder
Astellas Pharma Inc 1,263
Not applicableStudy completedNCT04823442
What this trial is testing

Activation of Brown Adipose Tissue Metabolism Using Mirabegron

Who this might be right for
Type 2 Diabetes
Université de Sherbrooke 9
Early research (Phase 1)Study completedNCT01646294
What this trial is testing

Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions

Who this might be right for
Pharmacokinetics of YM178Healthy Subjects
Astellas Pharma Europe B.V. 34
Testing effectiveness (Phase 2)UnknownNCT02354807
What this trial is testing

Efficacy of Pharmacological Stimulation of BAT and WAT in Lean and Obese Young Adults

Who this might be right for
Brown Fat
Otto Muzik 20
Early research (Phase 1)Study completedNCT01478490
What this trial is testing

To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol

Who this might be right for
Pharmacokinetics of MirabegronHealthy Subjects
Astellas Pharma Inc 28
Not applicableStudy completedNCT02570035
What this trial is testing

Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease

Who this might be right for
Overactive BladderCardiovascular Disease
Astellas Pharma Inc 316
Post-approval studies (Phase 4)Study completedNCT02495389
What this trial is testing

Mirabegron and Urinary Urgency Incontinence

Who this might be right for
Overactive Bladder
Loyola University 84
Post-approval studies (Phase 4)Looking for participantsNCT06479720
What this trial is testing

Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder

Who this might be right for
Effect of DrugUrinary Bladder, Overactive
Mackay Memorial Hospital 300
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation